THOMAS LEE
PHOENIX, AZ
Browse related groups: AZ Janssen Biotech, Inc. All categories
This page merges CMS profile IDs: 7232533, 7632381 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$1,816.14
- Category: General Payments
- Program years: PY2019–2024
- Record count: 82
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $258.17 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $158.18 | 7 |
| Education | $99.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $121.11 | 2 |
| ABBVIE INC. | $38.93 | 2 |
| Amgen Inc. | $34.21 | 1 |
| GENZYME CORPORATION | $28.59 | 1 |
| Lilly USA, LLC | $21.46 | 1 |
| Regeneron Healthcare Solutions, Inc. | $13.87 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078278529 | Janssen Biotech, Inc. | $21.12 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078279411 | Janssen Biotech, Inc. | $99.99 | 03/26/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1104156460 | ABBVIE INC. | $24.80 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104156462 | ABBVIE INC. | $14.13 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114098395 | Regeneron Healthcare Solutions, Inc. | $13.87 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117608540 | Amgen Inc. | $34.21 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135449304 | Lilly USA, LLC | $21.46 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139922183 | GENZYME CORPORATION | $28.59 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 7232533, 7632381
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.